Regulatory Story
Go to market news section View chart   Print
RNS
Renishaw PLC   -  RSW   

Half-year Report

Released 07:00 30-Jan-2020

RNS Number : 3556B
Renishaw PLC
30 January 2020
 

Renishaw plc                                                                     

 

30 January 2020

 

Interim report 2020 - for the six months ended 31 December 2019

 

 

Highlights 

 

 

 

 

 

6 months to

31 December

2019

6 months to

31 December

2018

Year ended

30 June

2019

 

 

 

 

 

Revenue (£m)

259.4

296.7

574.0

 

 

 

 

 

Adjusted1 profit before tax (£m)

14.3

59.6

103.9

 

 

 

 

Adjusted1 earnings per share (pence)

15.1

69.3

119.9

 

 

 

 

Dividend per share (pence) 2

14.0

14.0

60.0

 

 

 

 

Statutory profit before tax (£m)

9.9

61.6

109.9

 

 

 

 

Statutory earnings per share (pence)

10.2

71.5

126.7

 

 

 

 

1 Note 11, 'Alternative performance measures', defines how adjusted profit before tax and earnings per share are calculated.

2 All directors have waived their rights to the interim dividend - see note 7 for further details.

 

 

 

Chairman's and Chief Executive's statement

 

We report our Group results for the six months to 31 December 2019.

 

Highlights

 

·      First half year revenue of £259.4m, compared with previous year of £296.7m.

·      First half year adjusted1 profit before tax of £14.3m, compared with adjusted previous year of £59.6m.

·      First half year statutory profit before tax of £9.9m, compared with £61.6m last year.

·      Cash balances of £71.3m, compared with £106.8m at 30 June 2019.

 

Trading results

 

 

First half
2020

First half
2019

Change %

Constant fx change %

Group revenue

£259.4m

£296.7m

-13

-14

Comprising:

 

 

 

 

   APAC

£106.8m

£131.2m

-19

-20

   Americas

£63.6m

£65.4m

-3

-9

   EMEA

£89.0m

£100.1m

-11

-12

 

 

Revenue for the six months ended 31 December 2019 was £259.4m, compared with £296.7m for the corresponding period last year, with all regions experiencing a reduction in revenue.

 

It has been a challenging trading period for the Group due to the global macroeconomic environment, including the ongoing uncertainty caused by the trade tensions between the USA and China and weaker demand in the machine tool sector. The first half of 2019 also benefitted from a number of large orders from end-user manufacturers of consumer electronic products in the APAC region which have not been repeated this year.  There are however some positive indications of recovery in the semiconductor market which has benefitted our encoder lines.  

 

Adjusted profit before tax for the first half year was £14.3m compared with £59.6m last year, primarily due to the reduced revenue. Last year's first half benefitted from a £5.3m currency gain, primarily in respect of intra-group balances, compared with a loss of £2.0m in the first half of this year. This year also includes a £2.7m gain arising from the fair value adjustment of a convertible loan option in an associate company and a £2.0m charge from the impairment of intangible assets.

 

Statutory profit before tax for the first half year was £9.9m, compared with £61.6m last year, which includes a £2.2m charge for restructuring costs and a £2.1m loss from the fair value of derivatives not included in adjusted profit before tax.

 

Adjusted earnings per share were 15.1p, compared with 69.3p last year. Statutory earnings per share were 10.2p, compared with 71.5p last year.

 

Metrology

Revenue in our metrology business for the first six months was £241.5m, compared with £277.7m last year. Adjusted operating profit was £17.4m, compared with £52.2m for the comparable period last year. Despite subdued demand conditions overall, we have seen growth in our optical and laser encoder product lines due to a recovery in the semiconductor market.

 

Healthcare

Revenue from our healthcare business for the first six months was £17.8m, compared with £19.0m last year, but we did see growth in our neurological product line due to increased demand for our neurosurgical robot. The business recorded an adjusted operating loss of £1.5m in the first half of this year compared to break even in the corresponding period last year.

 

Operating costs

As previously communicated, due to the challenging trading conditions faced, we are taking a number of actions to improve productivity and to reduce the Group's cost base. These include the non-replacement of staff who have left the business, reductions in direct manufacturing staff in the UK, Ireland and India, and the planned closure of the Staffordshire site in February 2020 with activities consolidated in Gloucestershire and South Wales. We have also commenced a proposed UK compulsory redundancy programme that could lead to a headcount reduction of around 200 people (approximately 6% of total UK employees). We have reviewed all other areas of operating costs and reduced expenditure where appropriate.

 

Total Group headcount at the end of December 2019 was 4,871, a net reduction of 170 since June 2019.

 

 

 

The Group remains committed to our long-term strategy of delivering growth through the development and introduction of innovative and patented products and during the first six months of this year we incurred net engineering expenditure of £46.1m compared with £47.7m last year.

 

The directors thank employees for their valued support and contribution during this challenging period.    

 

Capital Expenditure

Capital expenditure for the first six months was £28.4m. Expenditure on property totalled £20.8m for the period, including the extension to our Innovation Centre in Wotton-under-Edge, Gloucestershire which is nearing completion; acquisition of property in Pune, India to provide capacity for future growth; refurbishment of the building purchased in Nagoya, Japan last year; and the construction of our new facility in Michigan, USA. Expenditure on plant and equipment for the period was £7.6m.

 

With the building projects listed nearing completion, capital expenditure in the second half of this year is planned to reduce significantly.

 

Working capital

Net cash balances at 31 December 2019 were £71.3m, compared with £100.5m at 31 December 2018 and £106.8m at 30 June 2019. 

 

Inventory balances at 31 December 2019 were £117.8m, a decrease of £11.2m since 30 June 2019, primarily

reflecting the reduction in trading activity.

 

Dividend

The Board has approved an interim dividend of 14.0 pence net per share (2019: 14.0 pence) which will be paid on 6 April 2020 to shareholders on the register on 6 March 2020. All directors have waived their rights to the interim dividend which results in the cost of the dividend being £4.8m compared to £10.2m last year.

 

Outlook

The Board believes that the structural demand drivers in our end-markets remain intact. The Group is in a strong financial position and we remain confident in the Group's long-term prospects due to the high quality of our people, our innovative product pipeline, extensive global sales and marketing presence and relevance to high-value manufacturing.

 

As indicated in our trading statement in October 2019, trading conditions are expected to remain challenging through the remainder of this financial year driven by the global macroeconomic environment. At this stage, we expect full year revenue to be in the range of £530m to £560m. Adjusted profit before tax is expected to be in the range of £50m to £70m, with profits in the second half of the year expected to benefit from an increase in revenue, reduced operating costs and a favourable currency impact from forward contracts compared to the first half year. Statutory profit before tax is expected to be in the range of £38m to £58m.

 

Investor Day

An Investor Day is being held on 12 May 2020 at our Gloucestershire headquarters and registration details will be published in due course.

 

Sir David McMurtry                                                          Will Lee                 

Executive Chairman                                                        Chief Executive

30 January 2020

 

 

 

 

 

1Note 11, 'Alternative performance measures', defines how adjusted profit before tax, operating profit and earnings per share are calculated.

 

 

 

Consolidated income statement

Unaudited

 

 

 

 

Continuing operations

 

 

 

 

Notes

 

 

6 months to

31 December

2019

£'000

 

 

6 months to

31 December

2018

£'000

 

Audited

Year ended

30 June

2019

£'000

 

Revenue

3

259,380

296,670

573,959

 

 

 

 

 

Cost of sales

 

(144,504)

(148,521)

(289,832)

 

 

 

 

 

Gross profit

 

114,876

148,149

284,127

 

 

 

 

 

Distribution costs

 

(65,580)

(63,766)

(126,822)

Administrative expenses

 

(31,933)

(29,002)

(58,593)

Gains/(losses) from the fair value of financial instruments - derivatives

10

(8,570)

(1,230)

1,081

Gains from the fair value of financial assets

12

2,700

-

-

 

 

 

 

 

Operating profit

 

11,493

54,151

99,793

 

 

 

 

 

Financial income

4

1,083

5,713

7,238

Financial expenses

4

(3,590)

(454)

(902)

Share of profits from associates and joint ventures

 

947

2,185

3,815

 

 

 

 

 

Profit before tax

 

9,933

61,595

109,944

 

 

 

 

 

Income tax expense

5

(2,538)

(9,572)

(17,712)

 

 

 

 

 

Profit for the period

 

7,395

52,023

92,232

 

 

 

 

 

Profit attributable to:

 

 

 

 

Equity shareholders of the parent company

 

7,395

52,023

92,232

Non-controlling interest

 

-

-

-

Profit for the period

 

7,395

52,023

92,232

 

 

 

 

 

 

 

pence

pence

Pence

Dividend per share arising in respect of the period

7

14.0

14.0

60.0

 

 

 

 

 

Earnings per share (basic and diluted)

6

10.2

71.5

126.7

 

  

 

Consolidated statement of comprehensive income and expense

Unaudited

 

 

6 months to

31 December

2019

£'000

 

 

6 months to

31 December

2018

£'000

 

Audited

Year ended

30 June

2019

£'000

 

 

 

 

Profit for the period

7,395

52,023

92,232

 

 

 

 

Other items recognised directly in equity:

 

 

 

 

 

 

 

Items that will not be reclassified to the Consolidated income statement:

 

 

 

Remeasurement of defined benefit pension scheme liabilities

2,417

13,254

10,273

Deferred tax on remeasurement of defined benefit pension scheme liabilities

(319)

(2,230)

(1,534)

 

 

 

 

Total for items that will not be reclassified

2,098

11,024

8,739

 

 

 

 

Items that may be reclassified to the Consolidated income statement:

 

 

 

Exchange differences in translation of overseas operations

(9,154)

1,934

2,045

Exchange differences in translation of overseas joint venture

(524)

(121)

72

Current tax on translation of net investments in foreign operations

763

-

(205)

Effective portion of changes in fair value of cash flow hedges, net of recycling

47,910

(23,686)

(27,573)

Deferred tax on effective portion of changes in fair value of cash flow hedges

(8,479)

4,058

4,561

 

 

 

 

Total for items that may be reclassified

30,516

(17,815)

(21,100)

 

 

 

 

Total other comprehensive income and expense, net of tax

32,614

(6,791)

(12,361)

 

 

 

 

Total comprehensive income and expense for the period

40,009

45,232

79,871

 

 

 

 

Attributable to:

 

 

 

Equity shareholders of the parent company

40,009

45,232

79,871

Non-controlling interest

-

-

-

 

 

 

 

Total comprehensive income and expense for the period

40,009

45,232

79,871

 

  

Consolidated balance sheet

Unaudited

 

 

 

 

Notes

 

At 31 December

2019

£'000

 

At 31 December

2018

£'000

Audited

At 30 June

2019

£'000

Assets

 

 

 

 

Property, plant and equipment

8

272,255

239,984

263,477

Intangible assets

9

58,626

56,342

59,056

Right of use assets

2

12,950

-

-

Investments in associates and joint ventures

 

13,006

11,514

13,095

Long-term loans to associates and joint ventures

 

519

3,322

750

Deferred tax assets

 

21,157

29,073

29,855

Derivatives

10

13,187

2,066

1,311

Total non-current assets

 

391,700

342,301

367,544

 

 

 

 

 

Current assets

 

 

 

 

Inventories

 

117,794

122,476

129,026

Trade receivables

 

101,508

127,811

123,151

Contract assets

 

99

477

352

Short-term loans to associates and joint ventures

12

10,203

-

6,644

Current tax

 

7,550

3,124

4,553

Other receivables

 

20,337

24,426

24,461

Derivatives

10

4,965

3,092

2,778

Pension scheme cash escrow account

 

10,490

10,451

10,490

Cash and cash equivalents

 

71,307

100,504

106,826

Total current assets

 

344,253

392,361

408,281

 

 

 

 

 

Current liabilities

 

 

 

 

Trade payables

 

15,141

23,698

21,513

Contract liabilities

 

6,723

4,952

5,631

Lease liabilities

2

4,463

-

-

Current tax

 

4,506

7,131

4,538

Provisions

 

2,473

2,952

2,846

Derivatives

10

5,975

30,222

18,920

Borrowings

 

1,073

-

1,043

Other payables

 

27,849

29,282

41,065

Total current liabilities

 

68,203

98,237

95,556

 

 

 

 

 

Net current assets

 

276,050

294,124

312,725

 

 

 

 

 

Non-current liabilities

 

 

 

 

Borrowings

 

9,628

-

9,356

Lease liabilities

2

8,469

-

-

Employee benefits

 

42,831

52,566

51,870

Deferred tax liabilities

 

539

188

539

Derivatives

10

16,391

24,928

35,227

Total non-current liabilities

 

77,858

77,682

96,992

 

 

 

 

 

Total assets less total liabilities

 

589,892

558,743

583,277

 

 

 

 

 

Equity

 

 

 

 

Share capital

 

14,558

14,558

14,558

Share premium

 

42

42

42

Own shares held

 

(404)

(404)

(404)

Currency translation reserve

 

5,661

14,478

14,577

Cash flow hedging reserve

 

(2,970)

(39,017)

(42,401)

Retained earnings

 

573,798

570,051

597,784

Other reserve

 

(216)

(388)

(302)

Equity attributable to the shareholders of the parent company

 

590,469

559,320

583,854

Non-controlling interest

 

(577)

(577)

(577)

Total equity

 

589,892

558,743

583,277

 

 

 

Consolidated statement of changes in equity

Unaudited

 

 

Share

capital

£'000

 

Share

premium

£'000

 

Own

shares

held

£'000

Currency

translation

reserve

£'000

Cash flow

hedging

reserve

£'000

 

Retained

earnings

£'000

 

Other

reserve

£'000

Non-

controlling

interest

£'000

 

 

 

Total

£'000

 

Balance at 1 July 2018

14,558

42

-

12,665

(19,389)

540,487

(460)

(577)

547,326

 

 

 

 

 

 

 

 

 

 

Profit for the period

-

-

-

-

-

52,023

-

-

52,023

 

 

 

 

 

 

 

 

 

 

Other comprehensive income and expense (net of tax)

 

 

 

 

 

 

 

 

 

Remeasurement of defined benefit pension liabilities

-

-

-

-

-

11,024

-

-

11,024

Foreign exchange translation differences

-

-

-

1,934

-

-

-

-

1,934

Relating to associates and joint ventures

-

-

-

(121)

-

-

-

-

(121)

Changes in fair value of cash flow hedges

-

-

-

-

(19,628)

-

-

-

(19,628)

Total other comprehensive income and expense

-

-

-

1,813

(19,628)

11,024

-

-

(6,791)

 

 

 

 

 

 

 

 

 

 

Total comprehensive income and expense

-

-

-

1,813

(19,628)

63,047

-

-

45,232

 

 

 

 

 

 

 

 

 

 

Transactions with owners recorded in equity

 

 

 

 

 

 

 

 

 

Share-based payments charge

-

-

-

-

-

-

72

-

72

Purchase of own shares

-

-

(404)

-

-

-

-

-

(404)

Dividends paid

-

-

-

-

-

(33,483)

-

-

(33,483)

Balance at 31 December 2018

14,558

42

(404)

14,478

(39,017)

570,051

(388)

(577)

558,743

 

 

 

 

 

 

 

 

 

 

Profit for the period

-

-

-

-

-

40,209

-

-

40,209

 

 

 

 

 

 

 

 

 

 

Other comprehensive income and expense (net of tax)

 

 

 

 

 

 

 

 

 

Remeasurement of defined benefit pension liabilities

-

-

-

-

-

(2,287)

-

-

(2,287)

Foreign exchange translation differences

-

-

-

(94)

-

-

-

-

(94)

Relating to associates and joint ventures

-

-

-

193

-

-

-

-

193

Changes in fair value of cash flow hedges

-

-

-

-

(3,384)

-

-

-

(3,384)

Total other comprehensive income and expense

-

-

-

99

(3,384)

(2,287)

-

-

(5,572)

 

 

 

 

 

 

 

 

 

 

Total comprehensive income and expense

-

-

-

99

(3,384)

37,922

-

-

34,637

 

 

 

 

 

 

 

 

 

 

Transactions with owners recorded in equity

 

 

 

 

 

 

 

 

 

Share-based payments charge

-

-

-

-

-

-

86

-

86

Purchase of own shares

-

-

-

-

-

-

-

-

-

Dividends paid

-

-

-

-

-

(10,189)

-

-

(10,189)

Balance at 30 June 2019

14,558

42

(404)

14,577

(42,401)

597,784

(302)

(577)

583,277

 

 

 

 

 

 

 

 

 

 

Profit for the period

-

-

-

-

-

7,395

-

-

7,395

 

 

 

 

 

 

 

 

 

 

Other comprehensive income and expense (net of tax)

 

 

 

 

 

 

 

 

 

Remeasurement of defined benefit pension liabilities

-

-

-

-

-

2,097

-

-

2,097

Foreign exchange translation differences

-

-

-

(8,392)

-

-

-

-

(8,392)

Relating to associates and joint ventures

-

-

-

(524)

-

-

-

-

(524)

Changes in fair value of cash flow hedges

-

-

-

-

39,431

-

-

-

39,431

Total other comprehensive income and expense

-

-

-

(8,916)

39,431

2,097

-

-

32,612

 

 

 

 

 

 

 

 

 

 

Total comprehensive income and expense

-

-

-

(8,916)

39,431

9,492

-

-

40,007

 

 

 

 

 

 

 

 

 

 

Transactions with owners recorded in equity

 

 

 

 

 

 

 

 

 

Share-based payments charge

-

-

-

-

-

-

86

-

86

Purchase of own shares

-

-

-

-

-

-

-

-

-

Dividends paid

-

-

-

-

-

(33,478)

-

-

(33,478)

Balance at 31 December 2019

14,558

42

(404)

5,661

(2,970)

573,798

(216)

(577)

589,892

 

 

Consolidated statement of cash flow

Unaudited

 

 

6 months to

31 December

2019

£'000

 

 

6 months to

31 December

2018

£'000

 

Audited

Year ended

30 June

2019

£'000

 

Cash flows from operating activities

 

 

 

Profit for the period

7,395

52,023

92,232

 

 

 

 

Adjustments for:

 

 

 

Amortisation of development costs

8,118

7,027

15,144

Amortisation of other intangibles

606

908

1,518

Amortisation of right of use assets

2,207

-

-

Impairment of goodwill and other intangibles

1,973

-

-

Impairment of property, plant and equipment

-

-

1,155

Depreciation

12,373

11,436

22,597

(Profit)/loss on sale of property, plant and equipment

(46)

79

148

Profit on sale of other intangibles

-

(455)

(455)

Remeasurement of defined benefit pension scheme liabilities from GMP equalisation

-

751

751

(Gains)/losses from the fair value of financial instruments - derivatives

2,120

(1,970)

(6,081)

Gains from the fair value of financial assets

(2,700)

-

-

Share of profits from associates and joint ventures

(947)

(2,185)

(3,815)

Financial income

(1,083)

(5,713)

(7,238)

Financial expenses

3,590

454

902

Share based payment expense

86

72

158

Tax expense

2,538

9,572

17,712

 

28,835

19,976

42,496

 

 

 

 

Decrease/(increase) in inventories

11,232

(11,913)

(18,463)

Decrease/(increase) in trade and other receivables

18,709

26,404

30,028

(Decrease)/increase in trade and other payables

(14,795)

(15,980)

(7,183)

(Decrease)/increase in provisions

(676)

(501)

(607)

 

14,470

(1,990)

3,775

 

 

 

 

Defined benefit pension contributions

(7,081)

(2,747)

(6,831)

Income taxes paid

(4,708)

(13,618)

(25,183)

 

 

 

 

Cash flows from operating activities

38,911

53,644

106,489

 

 

 

 

Investing activities

 

 

 

Purchase of property, plant and equipment

(28,398)

(19,643)

(56,792)

Development costs capitalised

(7,948)

(8,200)

(18,091)

Purchase of other intangibles

(2,864)

(2,620)

(4,161)

Sale of other intangibles

-

2,001

2,000

Sale of property, plant and equipment

990

3,241

4,713

Interest received

575

446

1,222

Dividends received from associates and joint ventures

512

614

614

Payments (to)/from pension scheme escrow account

-

(38)

(77)

Cash flows from investing activities

(37,133)

(24,199)

(70,572)

 

 

 

 

Financing activities

 

 

 

Interest paid

(99)

(16)

(57)

Increase in borrowings

1,169

-

10,486

Repayment of borrowings

(425)

-

(87)

Repayment of lease liabilities

(2,480)

-

-

Dividends paid

(33,478)

(33,483)

(43,672)

Purchase of own shares

-

(404)

(404)

Cash flows from financing activities

(35,313)

(33,903)

(33,734)

 

 

 

 

Net (decrease)/increase in cash and cash equivalents

(33,535)

(4,458)

2,183

Cash and cash equivalents at the beginning of the period

106,826

103,847

103,847

Effect of exchange rate fluctuations on cash held

(1,984)

1,115

796

Cash and cash equivalents at the end of the period

71,307

100,504

106,826

 

Responsibility statement

 

The condensed set of financial statements is the responsibility of, and has been approved by, the Directors. We confirm that to the best of our knowledge:

 

•               As required by DTR 4.2 of the Disclosure Rules and Transparency Rules, the condensed set of financial statements, which has been prepared in accordance with the applicable set of accounting standards, gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company and the undertakings included in the consolidation as a whole. The Interim report has been prepared in accordance with IAS 34, 'Interim Financial Reporting', as issued by the International Accounting Standards Board and as adopted by the EU.

 

•               The Interim report includes a fair review of the information required by:

 

(a)      DTR 4.2.7 of the Disclosure Rules and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

(b)      DTR 4.2.8 of the Disclosure Rules and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last Annual Report that could do so.

 

On behalf of the Board

 

Allen Roberts FCA

Group Finance Director

30 January 2020

 

 

 

 

 

 

 

 

Notes

 

1.         Basis of preparation

 

The Interim Report, which includes the condensed consolidated financial statements for the six months ended 31 December 2019, was approved by the Directors on 30 January 2020.

 

The condensed consolidated financial statements for the six months ended 31 December 2019 were prepared in accordance with International Accounting Standard 34 'Interim Financial Reporting' (IAS 34) as issued by the International Accounting Standards Board and as adopted by the European Union, and apply the same accounting policies, presentation and methods of calculation as were applied in the preparation of the Group's consolidated financial statements for the year ended 30 June 2019, except for income taxes which are accrued using the forecast tax rate for the financial year, and except for the adoption of new accounting standards as set out in note 2.

 

The condensed consolidated financial statements included in this Report have not been audited and do not constitute the Group's statutory accounts as defined in section 434 of the Companies Act 2006. The information relating to the year ended 30 June 2019 is an extract from the Group's published Annual Report for that year, which has been delivered to the Registrar of Companies, and on which the auditor's report was unqualified and did not contain any emphasis of matter or statements under section 498(2) or 498(3) of the Companies Act 2006.

 

The Group has considerable financial resources at its disposal, and having considered the current financial projections, the Directors believe that the Group is well placed to manage its business risks successfully. Having made appropriate enquiries, the Directors are satisfied that, at the time of approving the unaudited condensed consolidated financial statements, it is appropriate to continue to adopt a going concern basis of accounting.

 

Given the nature of some forward-looking information included in this report, which the Directors have given in good faith, this information should be treated with due caution.

 

2.         New accounting standards and policies

 

IFRS 16 'Leases'

 

Summary

 

IFRS 16 'Leases' replaces IAS 17 and related standards, and provides an accounting model under which substantially all leases are recognised on the balance sheet of the lessee. A 'right of use' asset is recognised, being the right to use the underlying asset of the lease, and a lease liability is also recognised on the balance sheet, being the obligation to make payments in respect of the use of the underlying asset.

 

The Group adopted IFRS 16 on 1 July 2019 using the modified retrospective transition approach (and has therefore not restated comparatives for the prior period) with the principal change being that leases previously classified as operating leases under IAS 17 were brought on to the balance sheet at 1 July 2019. The impact of IFRS 16 is disclosed later in this note.

 

In adopting IFRS 16 the Group took advantage of the following practical expedients permitted by the standard:

 

-       The right of use assets were measured at an amount based on the lease liability at adoption, and initial direct costs incurred when obtaining leases were excluded from this measurement

-       Reliance was placed on previous assessments of whether leases are onerous (the assessment of which determined that the impact of onerous leases was trivial)

-       Operating leases with a remaining lease term of less than 12 months at 1 July 2019 were accounted for as 'short-term leases'

 

 

 

 

 

 

Impact - at transition and subsequently

 

As IFRS 16 no longer distinguishes between operating leases and finance leases, operating lease commitments disclosed at 30 June 2019 were replaced with a lease liability and recognised at 1 July 2019, as follows:

 

£'000

Operating lease commitments as disclosed at 30 June 2019

16,390

Less: effect of discounting

(149)

Less: recognition differences and assumptions

(1,994)

Total lease liability recognised at 1 July 2019

14,247

 

                                                                               

The weighted average incremental borrowing rate applied to the Group's lease liabilities recognised in the consolidated balance sheet at 1 July 2019 was 2.4%.

 

The impact on the primary statements of adopting IFRS 16 at 1 July 2019 is summarised below:

 

Impact on the Consolidated balance sheet

 

At 1 July 2019

£'000

At 31 December 2019

£'000

 

 

 

Right of use assets

14,550

12,950

Deferred tax assets

56

Non-current assets

13,006

 

 

 

Lease liabilities

4,799

4,463

Other payables

291

Current liabilities

4,754

 

 

 

Lease liabilities

9,448

8,469

Deferred tax liabilities

-

Non-current liabilities

8,469

 

 

Total assets less total liabilities

(217)

 

 

 

Currency translation reserve

-

12

Retained earnings

-

(229)

 

 

 

Total equity

-

(217)

 

Right of use assets at 1 July 2019 consisted of £11,377,000 relating to property leases occupied for trading purposes, £3,013,000 relating to vehicle leases and a small amount relating to machinery leases.

 

Impact on the Consolidated income statement

The impact on the Consolidated income statement for the six months ended 31 December 2019 is to increase operating profit by £272,000 and increase finance costs by £557,000, therefore reducing profit before tax by £285,000. The aggregate of depreciation and interest expense will generally result in higher expenses in the earlier periods of leases than would have been the case under IAS 17.

 

Impact on the Consolidated cash flow statement

There is no change to net cash flow from the adoption of IFRS 16. Under IAS 17 operating lease payments were treated as operating cash outflows, however under IFRS 16 payments made at lease inception and subsequently (both principal and interest) are classified as financing outflows. The Group therefore shows both higher cash inflows from operating activities and higher cash outflows from financing activities under IFRS 16.

 

Accounting policy

 

As a lessee

At the lease commencement date the Group recognises a right of use asset for the leased item and a lease liability for any lease payments due.

 

Right of use assets are initially measured at cost, being the present value of the lease liability plus any initial costs incurred in entering the lease and less any lease incentives received. Right of use assets are subsequently depreciated on a straight-line basis from the commencement date to the earlier of i) the end of the useful life of the asset, or ii) the end of the lease term.

 

Lease liabilities are initially measured at the present value of the lease payments that are not paid at the commencement date, discounted using the incremental borrowing rate of the applicable entity. The lease liability is subsequently measured at amortised cost using the effective interest method and is remeasured if there is a change in future lease payments arising from a change in an index or rate (such as an inflation-linked increase), of if there is a change in the Group's assessment of whether it will exercise an extension or termination option. When this happens there is also a corresponding adjustment to the right-of-use asset.

Where the Group enters into leases with a lease term of 12 months or less, these are treated as 'short term' leases and are recognised on a straight-line basis as an expense in the Income Statement. The same treatment applies to low-value assets, which are typically IT equipment and office equipment.

 

As a lessor

The Group acts as a lessor for Renishaw-manufactured plant and equipment and determines at inception whether the lease is a finance or an operating lease.

 

Where the Group transfers the risks and rewards of ownership of lease assets to a third party, the Group recognises a receivable in the amount of the net investment in the lease, within Trade receivables. The lease receivable is subsequently reduced by the principal received, while an interest component is recognised as financial income in the Consolidated income statement.

 

Where the Group retains the risks and rewards of ownership of lease assets, it continues to recognise the leased asset in Property, plant and equipment. Income from operating leases is recognised on a straight-line basis over the lease term and recognised as Revenue rather than Other revenue as such income is not material.

 

3.         Segmental information

 

The Group manages its business in two segments, comprising metrology and healthcare products. The results of these are regularly reviewed by the Board to allocate resources to segments and to assess their performance. Within the operating segment of metrology, there are multiple product offerings with similar economic characteristics, and where the nature of the products and production processes and their customer bases are similar. More details of the Group's products and services are given in the Strategic report of the 2019 Annual report.

 

Whilst future revenue is difficult to predict given that the Group's outstanding order book is typically around one month's worth of revenue value, larger consumer electronics orders in the APAC region within the metrology segment typically fall in the first or last quarter of the financial year. In addition, the Group typically experiences lower demand in August and December, and so revenue and operating profits are typically lower in the first half of the year. This information is provided to allow for a better understanding of the results, and management do not believe that the business is 'highly seasonal' in accordance with IAS 34.

 

 

6 months to 31 December 2019

Metrology

Healthcare

Total

 

£'000

£'000

£'000

 

 

 

 

Revenue

241,545

17,835

259,380

Depreciation and amortisation

21,954

1,116

23,070

 

 

 

 

Operating profit before losses from fair value of financial instruments - derivatives

21,350

(1,286)

20,064

Share of profits from associates and joint ventures

947

-

947

Net financial gain/(expense)

-

-

(2,508)

Losses from the fair value of financial instruments - derivatives

-

-

(8,570)

 

 

 

 

Profit before tax

-

-

9,933

 

 

 

 

6 months to 31 December 2018

 

 

 

 

 

 

 

Revenue

277,717

18,953

296,670

Depreciation and amortisation

18,468

903

19,371

 

 

 

 

Operating profit before losses from fair value of financial instruments

55,171

211

55,382

Share of profits from associates and joint ventures

2,185

-

2,185

Net financial gain/(expense)

-

-

5,259

Losses from the fair value of financial instruments - derivatives

-

-

(1,230)

 

 

 

 

Profit before tax

-

-

61,596

 

 

 

 

Year ended 30 June 2019

 

 

 

 

 

 

 

Revenue

532,940

41,019

573,959

Depreciation and amortisation

37,714

2,700

40,414

 

 

 

 

Operating profit before gains from fair value of financial instruments - derivatives

95,345

3,367

98,712

Share of profits from associates and joint ventures

3,815

-

3,815

Net financial expense

-

-

6,336

Gains from the fair value of financial instruments - derivatives

-

-

1,081

 

 

 

 

Profit before tax

-

-

109,944

 

There is no allocation of assets and liabilities to operating segments. Depreciation is included within certain other overhead expenditure which is allocated to segments on the basis of the level of activity.

 

The following table shows the disaggregation of group revenue by category:

 

 

6 months to

31 December

2019

£'000

6 months to

31 December

2018

£'000

Year ended

30 June

2019

£'000

 

 

 

 

Goods, capital equipment and installation

232,145

269,569

519,782

Aftermarket services

27,235

27,101

54,177

 

 

 

 

Total group revenue

259,380

296,670

573,959

 

Aftermarket services include repairs, maintenance and servicing, programming, training, extended warranties, and software licences and maintenance.

 

The following table shows the analysis of revenue by geographical market:

 

 

6 months to

31 December

2019

£'000

6 months to

31 December

2018

£'000

Year ended

30 June

2019

£'000

 

 

 

 

APAC

106,801

131,181

240,115

EMEA

88,998

100,078

201,255

Americas

63,581

65,411

132,589

 

 

 

 

Total Group revenue

259,380

296,670

573,959

 

Revenue in the above table has been allocated to regions based on the geographical location of the customer. Countries with individually material revenue figures in the context of the Group were:

 

 

6 months to

31 December

2019

£'000

6 months to

31 December

2018

£'000

Year ended

30 June

2019

£'000

 

 

 

 

China

43,259

65,246

111,002

USA

52,698

54,961

113,235

Japan

30,635

33,212

63,650

Germany

27,178

31,477

60,916

 

There was no revenue from transactions with a single external customer amounting to 10% or more of the Group's total revenue

for the period.

  

4.         Financial income and expenses

 

 

 

 

 

6 months to

31 December

2019

£'000

6 months to

31 December

2018

£'000

Year ended

30 June

2019

£'000

Financial income

 

 

 

Currency gains

-

5,267

5,940

Fair value gains from 1 month forward currency contracts

508

-

76

Interest receivable

575

446

1,222

Total financial income

1,083

5,713

7,238

 

 

 

 

Financial expenses

 

 

 

Interest on pension schemes' liabilities

459

438

845

IFRS 16 lease interest

557

-

-

Currency losses

2,476

-

-

Bank interest payable

98

16

57

Total financial expenses

3,590

454

902

 

Currency gains relates to revaluations of foreign currency denominated balances using latest reporting currency exchange rates. The gain recognised in the six months to 31 December 2018 largely related to a depreciation of sterling relative to the dollar affecting dollar denominated intra-group balances in the Company (Renishaw plc).

Certain long-term intra-group receivable balances for which settlement is neither planned nor likely to occur were reclassified as net investments in foreign operations on 3 December 2018, such that revaluations from future currency movements on designated balances will accumulate in the Currency translation reserve in Equity. Additionally, from 1 January 2019, a policy of entering into rolling one month forward currency contracts began, with fair value gains and losses being recognised in financial income, to partially offset currency movements on remaining intra-group balances. After these mitigating activities, currency losses in the six months to 31 Decemebr 2019 amounted to £2,476,000.

 

5.         Taxation

 

The income tax expense in the Consolidated income statement has been estimated at a rate of 17.4% (December 2018: 15.5%) before a deferred tax asset impairment of £809,000, based on management's best estimate of the full year effective tax rates by geographical unit applied to half year profits. The impairment arises from uncertainty over the recoverability of a portion of previously recognised losses against future taxable profits in our US business. The effective tax rate including the impairment for the 6 months to 31 December 2019 is 25.6%.

Deferred tax assets and liabilities have been calculated based on the rate expected to be applicable when the relevant items are expected to reverse.

 

6.         Earnings per share

 

The earnings per share for the six months ended 31 December 2019 is calculated on earnings of £7,395,000 (December 2018: £52,023,000) and on 72,778,904 shares (December 2018: 72,778,904 shares), being the number of shares in issue during the period. This excludes 9,639 shares held by the Renishaw Employee Benefit Trust (EBT), which were purchased on 10 December 2018.

 

 

7.         Dividends

 

 

 

Dividends paid during the period were:

 

6 months to

31 December

2019

£'000

6 months to

31 December

2018

£'000

Year ended

30 June

2019

£'000

 

 

 

 

2019 final dividend of 46.0p per share (2018: 46.0p)

33,478

33,483

33,483

2019 interim dividend of 14.0p

-

-

10,189

 

 

 

 

Total dividends paid during the period

33,478

33,483

43,672

 

All Directors have waived their right to the interim dividend. All other shareholders on the register on 6 March 2020 will be paid an interim dividend of 14.0p net per share on 6 April 2020, resulting in a dividend payable of £4,782,067.

 

8.         Property, plant and equipment

 

 

 

 

 

Freehold

land and

buildings

£'000

 

Plant and

equipment

£'000

 

Motor

vehicles

£'000

Assets in the

course of construction

£'000

 

 

Total

£'000

Cost

 

 

 

 

 

At 1 July 2019

197,474

245,027

9,555

8,758

460,814

Additions

12,349

5,145

276

10,628

28,398

Transfers

34

1,077

-

(1,111)

-

Disposals

-

(3,099)

(687)

-

(3,786)

Currency adjustment

(5,077)

(3,929)

(242)

-

(9,248)

 

 

 

 

 

 

At 31 December 2019

204,780

244,221

8,902

18,275

476,178

 

 

 

 

 

 

Depreciation

 

 

 

 

 

At 1 July 2019

31,893

158,567

6,877

-

197,337

Charge for the period

1,671

10,106

596

-

12,373

Released on disposals

-

(2,189)

(653)

-

(2,842)

Currency adjustment

(882)

(1,892)

(171)

-

(2,945)

 

 

 

 

 

 

At 31st December 2019

32,682

164,592

6,649

-

203,923

 

 

 

 

 

 

Net book value

 

 

 

 

 

At 31 December 2019

172,098

79,629

2,253

18,275

272,255

At 30 June 2019

165,581

86,460

2,678

8,758

263,477

 

Additions to assets in the course of construction of £10,628,000 (December 2018: £5,528,000) comprise £8,412,000 (December 2018: £2,445,000) for freehold land and buildings and £2,216,000 (December 2018: £3,083,000) for plant and equipment.

At the end of the period, assets in the course of construction, not yet transferred, of £18,275,000 (December 2018: £5,958,000) comprise £14,269,000 (December 2018: £2,361,000) for freehold land and buildings and £4,006,000 (December 2018: £3,597,000) for plant and equipment.

 

9.         Intangible assets

 

 

 

Goodwill on consolidation

 

Other intangible assets

Internally

generated

development costs

Software

licences and intellectual property

Total

 

£'000

£'000

£'000

£'000

£'000

Cost

 

 

 

 

 

At 1 July 2019

20,227

13,823

150,042

20,827

204,919

Additions

-

1,900

7,948

964

10,812

Currency adjustment

(510)

(7)

-

(55)

(572)

 

 

 

 

 

 

At 31 December 2019

19,717

15,716

157,990

21,736

215,159

 

 

 

 

 

 

Amortisation

 

 

 

 

 

At 1 July 2019

8,220

11,260

108,954

17,429

145,863

Charge for the period

-

28

8,118

578

8,724

Impairment

403

1,571

-

-

1,974

Currency adjustment

-

7

-

(35)

(28)

 

 

 

 

 

 

At 31 December 2019

8,623

12,866

117,072

17,972

156,533

 

 

 

 

 

 

Net book value

 

 

 

 

 

At 31 December 2019

11,094

2,850

40,918

3,764

58,626

At 30 June 2019

12,007

2,563

41,088

3,398

59,056

 

Impairments of £1,973,000 at 31 December 2019 have been recognised in Administrative expenses in the Consolidated income statement due to the uncertain future cash flows relating to these assets.

 

10.       Financial instruments

 

There is no significant difference between the fair value of financial assets and financial liabilities and their book value in the Consolidated balance sheet. All financial assets and liabilities are held at amortised cost, apart from the forward exchange contracts and a convertible loan option, which are held at fair value, with changes going through the Consolidated income statement unless subject to hedge accounting.

The fair values of the forward exchange contracts have been calculated by a third party expert, discounting estimated future cash flows on the basis of market expectations of future exchange rates, representing level 2 in the IFRS 13 fair value hierarchy. There were no transfers between levels during any period disclosed.

At 31 December 2019 the total nominal value of USD contracts held for cash flow hedging purposes was $870,000,000, or £636,232,521. On the basis of a highly probable sales forecast according to IFRS 9 'Financial Instruments' of Renishaw plc (the Company) and Renishaw UK Sales Limited, a partial prospective discontinuation of contracts with nominal value of $133,130,000, or £96,802,000 (15.2% of total USD contracts) was necessitated. The fair value loss on such contracts at 31 December 2019 recognised in 'Gains/(losses) from the fair value of financial instruments - derivatives' was £3,030,000. Additionally, £3,317,000 of realised losses was accounted for in 'Gains/(losses) from the fair value of financial instruments - derivatives' relating to ineffective portions of contracts which matured in the six months to 31 December 2019. The remaining loss amount of £2,223,000 relates to fair value movements on option contracts, which are ineffective for cash flow hedging purposes.

On an ongoing basis as a consequence of the above, a 10% depreciation of the GBP:USD exchange rate would result in a £9,680,173 loss being recognised in the Consolidated Income Statement, while a 10% appreciation would result in a £8,800,157 gain.

Fair value gains and losses relating to this have been excluded from adjusted profit measures, see note 11 for further detail.

 

11.       Alternative performance measures

 

Alternative performance measures are - Revenue at constant exchange rates, Adjusted profit before tax, Adjusted earnings per share and Adjusted operating profit.

Revenue at constant exchange rates is defined as Revenue recalculated using the same rates as were applicable to the previous year and excluding forward contract gains and losses.

Revenue at constant exchange rates

 

 

6 months to 31 December 2019

6 months to 31 December 2018

 

 

£'000

£'000

 

 

 

 

Statutory revenue as reported

 

259,380

296,670

Adjustment for forward contract losses

 

7,324

10,265

Adjustment to restate at previous year exchange rates

 

(3,081)

-

 

 

 

 

Revenue at constant exchange rates

 

263,623

306,935

Year on year revenue growth at constant exchange rates

 

-14%

 

 

Adjusted profit before tax, Adjusted earnings per share and Adjusted operating profit - These measures are defined as the profit before tax, earnings per share and operating profit after excluding gains and losses in fair value from forward currency contracts which did not qualify for hedge accounting and which have yet to mature, and costs relating to business restructuring.

 

The gains and losses from fair value of financial instruments not effective for cash flow hedging have been excluded from statutory profit before tax, statutory earnings per share and statutory operating profit in arriving at adjusted profit before tax, adjusted earnings per share and adjusted operating profit to reflect the Board's intent that the instruments would provide effective hedges. This is classified as 'Fair value (gains)/losses on financial instruments not eligible for hedge accounting (i)' in the following reconciliations.

 

This includes gains or losses from fair value movements on derivatives deemed partially ineffective 31 December 2019. Such contracts are still expected to achieve management's hedging intent for the consolidated Group, despite failing certain elements of IFRS 9 hedge effectiveness criteria. This is classified as 'Fair value (gains)/losses on financial instruments not eligible for hedge accounting (ii)' in the following reconciliations.

 

Restructuring costs accounted for in Cost of sales, Distribution costs and Administrative expenses relating to the planned closure of the Staffordshire site and reductions in direct manufacturing staff in the UK have also been excluded from these alternative performance measures.

 

The Board considers these alternative performance measures to be more relevant and reliable in evaluating the Group's performance.

 

Adjusted profit before tax

 

6 months to 31 December 2019

6 months to 31 December 2018

Year ended 30 June 2019

 

£'000

£'000

£'000

 

 

 

 

Statutory profit before tax

9,933

61,596

109,944

 

 

 

 

Restructuring costs reported in Cost of sales, Distribution costs and Administrative expenses

2,249

-

-

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (i)

 

 

 

  - reported in revenue

(3,133)

(3,200)

(5,001)

  - reported in (gains)/losses from the fair value of financial instruments - derivatives

2,223

1,230

(1,081)

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (ii)

 

 

 

  - reported in (gains)/losses from the fair value of financial instruments - derivatives

3,030

-

-

 

 

 

 

Adjusted profit before tax

14,302

59,626

103,862

 

Adjusted earnings per share

 

6 months to 31 December 2019

6 months to 31 December 2018

Year ended 30 June 2019

 

pence

pence

pence

 

 

 

 

Statutory earnings per share

10.2

71.5

126.7

 

 

 

 

Restructuring costs reported in Cost of sales, Distribution costs and Administrative expenses

2.5

-

-

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (i)

 

 

 

  - reported in revenue

(3.5)

(3.6)

(5.6)

  - reported in (gains)/losses from the fair value of financial instruments - derivatives

2.5

1.4

(1.2)

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (ii)

 

 

 

  - reported in (gains)/losses from the fair value of financial instruments - derivatives

3.4

-

-

 

 

 

 

 

 

 

 

Adjusted earnings per share

15.1

69.3

119.9

 

Adjusted operating profit

 

6 months to 31 December 2019

6 months to 31 December 2018

Year ended 30 June 2019

 

£'000

£'000

£'000

 

 

 

 

Statutory operating profit

11,493

54,151

99,793

 

 

 

 

Restructuring costs reported in Cost of sales, Distribution costs and Administrative expenses

2,249

 

 

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (i)

 

 

 

  - reported in revenue

(3,133)

(3,200)

(5,001)

  - reported in (gains)/losses from the fair value of financial instruments - derivatives

2,223

1,230

(1,081)

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (ii)

 

 

 

  - reported in (gains)/losses from the fair value of financial instruments - derivatives

3,030

-

-

 

 

 

 

Adjusted operating profit

15,862

52,181

93,711

 

 

Adjustments to segmental operating profit:

Metrology

 

6 months to 31 December 2019

6 months to 31 December 2018

Year ended 30 June 2019

 

£'000

£'000

£'000

 

 

 

 

Operating profit before gain/loss from fair value of financial instruments - derivatives

21,350

55,171

95,345

 

 

 

 

Restructuring costs reported in Cost of sales, Distribution costs and Administrative expenses

2,249

 

 

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (i)

 

 

 

  - reported in revenue

(2,919)

(2,998)

(4,745)

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (ii)

 

 

 

  - reported in revenue

(3,318)

-

-

 

 

 

 

Adjusted metrology operating profit

17,362

52,173

90,600

 

Healthcare

 

6 months to 31 December 2019

6 months to 31 December 2018

Year ended 30 June 2019

 

£'000

£'000

£'000

 

 

 

 

Operating loss before gain/loss from fair value of financial instruments - derivatives

(1,286)

211

3,367

Fair value (gains)/losses on financial instruments not eligible for hedge accounting (i)

 

 

 

  - reported in revenue

(214)

(202)

(256)

 

 

 

 

Adjusted healthcare operating profit

(1,500)

9

3,111

 

 

 

 

 

12.       Related party transactions and post balance sheet events

 

Transactions between the Company and its subsidiaries, which are related parties, have been eliminated on consolidation and are not disclosed in this note.

Full details of the Group's other related party relationships, transactions and balances are given in the Group's Annual report for the year ended 30 June 2019.

No related party transactions have taken place in the first six months of the financial year that have materially affected the financial position or the performance of the Group during that period.

On 6 January 2020 a third party acquired shares in our associate company, HiETA Technologies Limited. As part of the transaction, Renishaw plc converted a loan to share capital in HiETA, disposed of a proportion of our shareholding and the remaining shareholding was diluted following a share issue to the third party. Following the transaction, Renishaw plc has a 33.33% shareholding in the company. Given the high level of confidence at 31 December 2019 that the transaction would complete in January, a fair value gain of £2,700,000 has been recognised in the Consolidated income statement and the Consolidated balance sheet in respect of the convertible loan option. The fair value adjustment reflects a valuation for the company based on the cash consideration paid by the third party for it's shareholding.

 

13.       Principal risks and uncertainties

 

A number of potential risks and uncertainties exist which could have an impact on the Group's performance. The Group has processes in place for identifying, evaluating and managing principal risks. These risks, together with a description of our approach to mitigating them, are set out on pages 40 to 42 of the Annual report 2019, which is available on the Group's website at www.renishaw.com.

We continue to monitor the current economic uncertainties, particularly those arising from trading conditions between the US and China. If prolonged, this could continue to have an adverse impact on group revenue as a result of reduced demand for products manufactured by our customers, particularly in China.

Following the referendum in June 2016 and the subsequent triggering of Article 50 in March 2017, the UK is scheduled to leave the European Union on 31 January 2020 ("Brexit"). The decision has led to a higher level of uncertainty surrounding trading conditions, particularly between the UK and the EU. In the year ended 30 June 2019, 25% of group revenue resulted from trading with the EU.

Renishaw has a Brexit steering group which assesses and monitors the potential impact on the Group and which manages the implementation of mitigation plans.

With a strong direct presence in the EU, the Board believes that Renishaw is well placed to respond to changes to future trading arrangements between the EU and the UK. The establishment of a distribution warehouse in Ireland is complete which, if required, will significantly reduce the number of direct shipments from the UK to the EU post Brexit. Inventory holdings of certain components and finished goods have been increased at our various sites within the EU and UK to mitigate the risk of delays in customs and border clearances.

Other than set out above, the Directors do not consider that the principal risks and uncertainties have changed since the publication of the Annual report 2019 and confirm that they remain relevant for the second half of the financial year.

 

 

 

Financial calendar

2020 interim dividend record date                                      6 March 2020

2020 interim dividend payment date                                   6 April 2020

Investor day                                                                        12 May 2020

Announcement of 2020 full year results                              3 August 2020

Publication of 2020 Annual report                                       Late August 2020

Annual general meeting                                                       22 October 2020

2020 final dividend record date (provisional)                       25 September 2020

2020 final dividend payment date (provisional)                   29 October 2020

 

 

 

Registered office:

 

Renishaw plc

New Mills

Wotton-under-Edge

Gloucestershire

GL12 8JR

UK

 

Registered number:                01106260

LEI number:                            21380048ADXM6Z67CT18

Telephone:                            +44 1453 524524

Email:                                      uk@renishaw.com

Website:                                  www.renishaw.com


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR PPUWCGUPUGRB
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Half-year Report - RNS